The gut microbiota contributes to the pathophysiology of non-alcoholic fatty liver disease
(NAFLD). Histidine is a key energy source for the microbiota, scavenging it from the host. Its …

The contribution of gut-liver signaling to the development of non-alcoholic hepatic steatosis
(NHS) in non-diabetic adults remains unclear. We therefore performed comprehensive 16S …

Background/Aims: Emerging evidence suggests a close link between gut microbiota and
non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to investigate the …

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and
progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory …

Non-alcoholic fatty liver disease (NAFLD), the world's most common chronic liver disease, is
increasingly linked to gut dysbiosis. Paneth cells secrete antimicrobial peptides that regulate …

Obesity is a major public health issue as it is causally associated with several chronic
disorders, including type-2 diabetes, cerebrovascular disease (CVD), and cancer. In the …

A carbohydrate-restricted diet is a widely recommended intervention for non-alcoholic fatty
liver disease (NAFLD), but a systematic perspective on the multiple benefits of this diet is …

Numerous studies have described specific metabolites as biomarkers of severe liver
diseases, but very few have measured gut microbiota (GM)-produced metabolites in fatty …

The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), which is a
progressive disease, has exerted huge a healthcare burden worldwide. New investigations …

Background and Purpose Non‐alcoholic fatty liver disease (NAFLD) represents a severe
public health problem. It often coexists with hypertension in the context of metabolic …